Dossier
press
news report
Longevity sector ambitions outpace regulatory and investment frameworks
Key claim: Pharmaceutical Technology reports that commercial longevity sector growth and clinical ambitions continue to outpace existing regulatory and investment frameworks.
Abstract
News coverage by Pharmaceutical Technology: “Longevity sector ambitions outpace regulatory and investment frameworks”. Headline and link only — this finding reports press coverage of a government action, not the primary record.
Why this matters
Pharmaceutical Technology reports that commercial longevity sector growth and clinical ambitions continue to outpace existing regulatory and investment frameworks.